Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2012
09/20/2012US20120238643 Inactivation of off-taste inducing enzymes
09/20/2012US20120238642 Polymer Mechanical Damping Composites and Methods of Production
09/20/2012US20120238640 Polymer Derivatives Comprising an Imide Branching Point
09/20/2012US20120238630 Compositions comprising nonsteroidal anti - inflammatory drugs
09/20/2012US20120238592 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocylcial Guanidine
09/20/2012US20120238487 Polymer composition useful as a pharmaceutical carrier
09/20/2012US20120237666 Preformulation for Tabletting Natural Mixtures of Conjugated Estrogens
09/20/2012US20120237603 Abuse-resistant opioid dosage form
09/20/2012US20120237581 Method Of Producing A Silicone Powder-Containing Oil Composition
09/20/2012US20120237575 Film coating agent for solid preparation, and solid preparation using same
09/20/2012US20120237569 Emulsified composition for dilution and cancer vaccine composition
09/20/2012US20120237557 Bioactive carbon-nanotube agarose composites for neural engineering
09/20/2012US20120237556 Topical base and active agent-containing compositions, and methods for improving and treating skin
09/20/2012US20120237548 Pharmaceutical compositions containing botulinum neurotoxin
09/20/2012US20120237477 Methods and compositions for treating post-myocardial infarction damage
09/20/2012US20120237465 Hydrolytically Stable Multi-Purpose Polymer
09/20/2012US20120237464 Hydrophilically-modified silicone compositions
09/20/2012US20120237461 Skin compositions and methods of use thereof
09/20/2012US20120237445 Stabilization of radiopharmaceutical compositions using ascorbic acid
09/20/2012US20120233929 Method of inhibiting water adsorption of powder by addition of hydrophobic nanaoparticles
09/20/2012CA2830349A1 Re-directed immunotherapy
09/20/2012CA2830298A1 Topical nitric oxide systems and methods of use thereof
09/20/2012CA2829825A1 Colonoscopy - preparation
09/20/2012CA2829693A1 Pegylated apelin and uses thereof
09/20/2012CA2829164A1 An ophthalmic composition
09/20/2012CA2828797A1 Improvements to immobilised biological entities
09/20/2012CA2828747A1 Porous disintegratable solid substrate for personal health care applications
09/20/2012CA2828688A1 Method for preparing multiple antigen glycopeptide carbohydrate conjugates
09/20/2012CA2828513A1 Thermo-responsive hydrogel compositions
09/19/2012EP2500348A1 Phospholipid derivative and ph-responsive liposomes
09/19/2012EP2500039A1 Oligomer-antihistamine conjugates
09/19/2012EP2500038A1 Pharmaceutical composition for external use
09/19/2012EP2500035A1 Pharmaceutical formulation containing immunglobulin
09/19/2012EP2500033A1 Method for preparing muliple antigen glycopeptide carbohydrate conjugates
09/19/2012EP2500023A1 Antibiotics composition comprising beta-lactam antibiotic, beta-lactamase inhibitor, and buffer component
09/19/2012EP2500016A1 Doxylamine resinate complex
09/19/2012EP2500015A1 Delivery of drugs
09/19/2012EP2500014A2 Slow release pharmaceutical composition made of microparticles
09/19/2012EP2499914A1 Antiseptic solutions comprising chlorhexidine or its salt and an anionic dye and their preparation
09/19/2012EP2499913A1 Antiseptic solutions comprising chlorhexidine or its salt and an anionic dye and their preparation
09/19/2012EP2498903A2 Emulsion template method to form small particles of hydrophobic agents with surface enriched hydrophilicity by ultra rapid freezing
09/19/2012EP2498830A2 Dextran-hyaluronic acid based hydrogels
09/19/2012EP2498824A2 Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers
09/19/2012EP2498823A1 Direct protein delivery with engineered microvesicles
09/19/2012EP2498822A1 Conjugate molecule
09/19/2012EP2498821A1 Anti integrin antibodies linked to nanoparticles loaded with chemotherapeutic agents
09/19/2012EP2498820A2 Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
09/19/2012EP2498819A2 Topical etoricoxib formulation comprsing an eutectic mixture of permeation enhancers
09/19/2012EP2498818A2 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
09/19/2012EP2498805A1 Aqueous composition comprising gold nanoparticles, serum albumin and/or collagen for laser tissue welding
09/19/2012EP2498802A1 Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
09/19/2012EP2498801A1 Pharmaceutical composition comprising a glp-1 agonist and methionine
09/19/2012EP2498800A1 Long-acting y2 receptor agonists
09/19/2012EP2498770A2 Pharmaceutical composition
09/19/2012EP2498764A1 Fragmented hydrogels
09/19/2012EP2498763A1 Polysaccharide based hydrogels
09/19/2012EP2498760A1 Delivery carrier
09/19/2012EP2498753A2 Nanosuspension of a poorly soluble drug made by microfluidization process
09/19/2012EP2498749A1 Polysaccharide gel formulation having multi-stage bioactive agent delivery
09/19/2012CN1615120B Solid galenical for the ocular administration of an active ingredients, a soluble, solid ophthalmic insert and the production method thereof
09/19/2012CN1607006B Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
09/19/2012CN102686676A Turmeric pigment composition and method for preparing same
09/19/2012CN102686612A Conjugates targeting the CD163 receptor
09/19/2012CN102686607A Double-acylated GLP-1 derivatives
09/19/2012CN102686603A Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
09/19/2012CN102686518A Magnetic iron oxide microparticle powder, aqueous dispersion containing magnetic particles, and process for production of same
09/19/2012CN102686245A Sterilization of biodegradable hydrogels
09/19/2012CN102686244A Immunonanotherapeutics providing a Th1-biased response
09/19/2012CN102686243A Polymeric systems for the delivery of anticancer agents
09/19/2012CN102686242A Chemically amplified response strategies for medical sciences
09/19/2012CN102686241A Antibody formulation
09/19/2012CN102686240A Transdermal pharmaceutical compositions comprising active agents
09/19/2012CN102686226A Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
09/19/2012CN102686208A Microcapsules comprising benzoyl peroxide and topical compositions comprising them
09/19/2012CN102677226A Preparation method of organic-inorganic hybrid electrostatic spinning nano drug-loaded fiber
09/19/2012CN102676563A Method for preparing human serum albumin-human parathyroid hormone
09/19/2012CN102676100A Medical hot melt pressure sensitive adhesive substrate and preparation method thereof
09/19/2012CN102675655A Water-soluble fullerene and preparation and application methods thereof
09/19/2012CN102675624A Polymer-modified protoheme and method for preparing same
09/19/2012CN102675621A Poloxamer-niacin prodrug and preparation method thereof
09/19/2012CN102675567A Water-soluble degradable and efficiently antibacterial polymeric micelle and preparation method thereof
09/19/2012CN102675565A Carbon quantum dot-poly N-isopropylacrylamide composite material and preparation method thereof
09/19/2012CN102675470A SCF (Stem Cell Factor)-Fc fusion protein
09/19/2012CN102675466A Epitope delivery system with Escherichia coli heat labile enterotoxin B subunits serving as carriers
09/19/2012CN102675464A Co-immobilized cytokine, preparation method and applications thereof
09/19/2012CN102675462A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
09/19/2012CN102675452A Human insulin/analogue conjugate with continuous blood sugar reduction function and high rate of combination with receptor
09/19/2012CN102675420A Synthetic decapeptide and method for promoting generation of fish yolk
09/19/2012CN102675419A Abeta oligopeptide polymerization inhibitor and preparation and application thereof
09/19/2012CN102671645A Multi-element composite metal oxide hollow nanosphere and preparation method thereof
09/19/2012CN102671625A Method for preparing graphene magnetic nanometer composite materials
09/19/2012CN102671215A Chitosan nanoparticle composite as well as preparation method and application thereof
09/19/2012CN102671214A Camptothecin supramolecular micelle prodrug for reducing, degrading and releasing drugs and preparation method and application
09/19/2012CN102671213A Scutellarin prodrug and preparation method thereof
09/19/2012CN102671212A Use of shea butter as transdermal osmosis promoter
09/19/2012CN102671211A Application of mango butter as penetration enhancer
09/19/2012CN102671210A Clathrate compound of beta-cyclodextrin or derivatives of beta-cyclodextrin for Nifuroxazide and preparation method for preparation of clathrate compound
09/19/2012CN102671209A Heat-resistant freeze-drying protective agent for newcastle disease live vaccines and preparation method
09/19/2012CN102671208A Heat-resisting freeze-dried protective agent for live vaccine for chicken infectious bursal diseases and preparation method for heat-resisting freeze-dried protective agent
09/19/2012CN102671207A Newcastle disease and avian infectious bronchitis bigeminal live vaccine heat-resisting freeze-drying protective agent and preparation method
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 1712